中東・アフリカのニードルフリー注射システム市場：2028年までの予測-製品、技術、タイプ、使用感、送達部位、用途、エンドユーザー別、地域別分析

中東・アフリカのニードルフリー注射システム市場は、2022年の725万米ドルから2028年には1,789万米ドルに成長すると予測され、2022年から2028年にかけて16.3%のCAGRで成長すると推定されています。

針刺し損傷による伝染病の発生率の増加が中東・アフリカの無針注射システム市場を押し上げる

針刺し損傷（NSI）は、ほとんどの医療従事者にとって大きな関心事の一つであり、最も深刻な健康と安全の脅威の一つと考えられています。2020年の医療従事者の針刺し損傷のプール有病率は32.4%でした。さらに、International Journal of Environment Research &Public Health 2022に掲載された論文によると、サウジアラビアにおけるNSIの発生率は医師（36%）が最も高く、次いで看護師（34.8%）、歯科医（29.2%）、医療技師（21.1%）となっています。このように、上記の要因が中東・アフリカのニードルフリー注射システム市場の成長を後押ししています。

中東・アフリカの無針注射器市場の概要

中東・アフリカの無針注射器市場は、UAE、サウジアラビア、南アフリカ、その他中東・アフリカに区分されます。サウジアラビアは、中東・アフリカの無針注射器市場で最大のシェアを占めています。これは、同地域で製品を発売するための市場関係者の戦略的イニシアチブの増加、慢性疾患の発生率の上昇、同地域でのワクチンニーズの高まりに伴うヘルスケアインフラの成長などのいくつかの要因によります。

サウジアラビアは中東・アフリカ地域で最も成長著しい地域のひとつで、糖尿病、心血管疾患、がん、自己免疫疾患などの慢性疾患の有病率の増加がその成長の原動力となっています。健康問題に対する意識の高まりや、注射薬の無針注射の採用が進んでいることが、無針注射システム市場の成長を後押しする要因となっています。サウジアラビアでは慢性疾患の負担が大きく、中東・アフリカの無針注射器市場の需要を高めると期待されています。

世界保健機関（WHO）は、サウジアラビアを中東で2番目、世界で7番目に高い糖尿病罹患率に位置づけています。サウジアラビアでは、700万人が糖尿病、300万人以上が糖尿病予備軍と推定されています。サウジアラビアでは、過去20年間で、糖尿病のヘルスケアと治療にかかる費用が500％以上増加しています。糖尿病患者において、無針注射器は痛みを伴わず、使いやすい治療法としてインスリンの注入に使用することができます。このように、無針注射器の需要は増加しており、中東・アフリカの無針注射器市場の成長を後押ししています。

中東・アフリカの無針注射システム市場の収益と2028年までの予測（US$Million）

中東・アフリカの無針注射システム市場のセグメンテーション

中東＆アフリカの無針注射システム市場は、製品、技術、タイプ、耐久性、国別に区分されます。製品に基づき、中東・アフリカの無針注射システム市場は、充填式無針注射器とプレフィルド無針注射器に二分されます。2022年の市場では、充填式無針注射器セグメントがより大きなシェアを占めています。

技術に基づき、中東・アフリカのニードルフリー注射システム市場は、ジェットベースのニードルフリー注射器、スプリングベースのニードルフリー注射器、マイクロアレイパッチ注射器、およびその他に区分されます。ジェットベースニードルフリーインジェクターセグメントは、2022年に市場で最大のシェアを登録しました。

タイプに基づき、中東・アフリカのニードルフリー注射システム市場は、液体ベースのニードルフリー注射器、発射体ベースのニードルフリー注射器、および粉末ベースのニードルフリー注射器に区分されます。液体ベースの無針注射器セグメントは、2022年に市場で最大のシェアを登録しました。

耐久性に基づいて、中東・アフリカの無針注射器市場は、使い捨てと再利用可能なものに二分されます。再利用可能なセグメントは、2022年に市場でより大きなシェアを占めています。

送達部位に基づき、中東・アフリカのニードルフリー注射システム市場は、皮下注射器、筋肉内注射器、皮内注射器に区分されます。皮下注射器セグメントは、2022年に市場で最大のシェアを占めています。

用途に基づき、中東・アフリカの無針注射器市場は、ワクチンデリバリー、インスリンデリバリー、腫瘍学、疼痛管理、皮膚科学、その他に区分されます。2022年の市場では、ワクチンデリバリー分野が最大のシェアを占めています。

エンドユーザーに基づき、中東・アフリカのニードルフリー注射システム市場は、病院、在宅ケア設定、研究室、製薬・バイオテクノロジー企業、その他に区分されます。2022年の市場規模は、病院セグメントが最大シェアを占めています。

国別に見ると、中東・アフリカのニードルフリー注射システム市場は、サウジアラビア、南アフリカ、UAE、その他中東・アフリカに区分されます。2022年はサウジアラビアが市場を独占しています。

Aijex Pharma International Inc.、Crossject、Ferring B.V.、Zealand Pharma A/Sは、中東＆アフリカのニードルフリー注射システム市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

• 調査範囲
• 調査報告書ガイダンス
• 市場セグメンテーション
  • 中東・アフリカのニードルフリー注射システム市場：製品別
  • 中東・アフリカのニードルフリー注射システムの市場：技術別
  • 中東・アフリカのニードルフリー注射システムの市場：タイプ別
  • 中東・アフリカのニードルフリー注射システムの市場：使用感別
  • 中東・アフリカのニードルフリー注射システムの市場：投与部位別
  • 中東・アフリカのニードルフリー注射システムの市場：用途別
  • 中東・アフリカのニードルフリー注射システムの市場：エンドユーザー別
  • 中東・アフリカのニードルフリー注射システムの市場：国別

第2章 中東・アフリカのニードルフリー注射システム市場-主要な要点

第3章 調査手法

• 調査範囲
• 2次調査
• 1次調査

第4章 中東・アフリカのニードルフリー注射システム市場- 市場情勢

• 中東・アフリカのPEST分析
• 専門家の見解

第5章 中東・アフリカのニードルフリー注射器市場- 主要な市場力学

• 市場促進要因
  • 針刺し損傷別伝染病の発生率の増加
  • 自己注射器を使用することの利点
• 市場抑制要因
  • 従来の注射器と比べたニードルフリー注射器の開発コストの高さ
• 市場機会
  • ワクチンやバイオシミラーの需要増加
• 今後の動向
  • ニードルフリー注射器に関する新技術の急増
• 影響度分析

第6章 ニードルフリー注射システム市場-中東・アフリカ分析

• 中東・アフリカのニードルフリー注射システムマーカーの収益と予測・分析

第7章 中東・アフリカのニードルフリー注射システム市場の分析と2028年までの予測- 製品別

• 中東・アフリカニードルフリー注射システム市場：製品別2022年・2028年（%）
• 充填式ニードルフリー注射器
• プレフィルドニードルフリーインジェクター（Prefilled Needle Free Injectors

第8章 ニードルフリー注射器市場の分析と2028年までの予測：技術別

• 中東・アフリカのニードルフリー注射システム市場：技術別2022年・2028年（%）
• ジェットベース・ニードルフリーインジェクター
• スプリング式ニードルフリーインジェクター
• マイクロアレイパッチインジェクター
• その他

第9章 ニードルフリー注射器市場の分析と2028年までの予測：タイプ別

• 中東・アフリカのニードルフリー注射システム市場：タイプ別2022年・2028年（%）
• 液体ベースのニードルフリー注射器
• 投射型ニードルフリー注射器
• パウダーベースのニードルフリー注射器

第10章 中東・アフリカのニードルフリー注射器市場の分析と2028年までの予測（ユーザビリティ別

• 中東・アフリカのニードルフリー注射システム市場：使用性別2022年・2028年（%）
• ディスポーザブル
• 再利用可能

第11章 中東・アフリカのニードルフリー注射システム市場の分析と2028年までの予測：送達部位別

• 中東・アフリカのニードルフリー注射システム市場：投与部位別2022年・2028年（%）
• 皮下注射器
• 筋肉内注射器
• 皮内注射器

第12章 中東・アフリカのニードルフリー注射システムの市場分析と2028年までの予測（用途別

• 中東・アフリカのニードルフリー注射システム市場：アプリケーション別2022年・2028年（%）
• ワクチンデリバリー
• インスリンデリバリー
• 疼痛管理
• 腫瘍学
• 皮膚科学
• その他

第13章 中東・アフリカのニードルフリー注射システムの市場分析-エンドユーザー別

• 中東・アフリカのニードルフリー注射システム市場：エンドユーザー別2022年・2028年（%）
• 製薬会社、バイオテクノロジー企業
• 病院
• 研究機関
• 在宅医療施設
• その他のエンドユーザー

第14章 中東・アフリカのニードルフリー注射システム市場の収益と2028年までの予測- 国別分析

• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • UAE
  • 中東・アフリカの残りの地域

第15章 ニードルフリー注射システム市場-業界情勢

• 市場参入企業の成長戦略（%）
• 有機的な展開
• インオーガニックの開発

第16章 企業プロファイル

• Crossject
• Zealand Pharma A/S
• Medical International Technologies（MIT Canada）Inc.
• NuGen Medical Devices
• Ferring B.V.

第17章 付録

• The Insight Partners について
• 用語集

List Of Tables

• Table 1. Saudi Arabia Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousand)
• Table 2. Saudi Arabia Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousand)
• Table 3. Saudi Arabia Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousand)
• Table 4. Saudi Arabia Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousand)
• Table 5. Saudi Arabia Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousand)
• Table 6. Saudi Arabia Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
• Table 7. Saudi Arabia Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousand)
• Table 8. South Africa Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousand)
• Table 9. South Africa Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousand)
• Table 10. South Africa Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousand)
• Table 11. South Africa Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousand)
• Table 12. South Africa Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousand)
• Table 13. South Africa Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
• Table 14. South Africa Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousand)
• Table 15. UAE Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousand)
• Table 16. UAE Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousand)
• Table 17. UAE Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousand)
• Table 18. UAE Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousand)
• Table 19. UAE Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousand)
• Table 20. UAE Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
• Table 21. UAE Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousand)
• Table 22. Rest of MEA Needle Free Injection System Market, by Product - Revenue and Forecast to 2028 (USD Thousand)
• Table 23. Rest of MEA Needle Free Injection System Market, by Technology- Revenue and Forecast to 2028 (USD Thousand)
• Table 24. Rest of MEA Needle Free Injection System Market, by Type - Revenue and Forecast to 2028 (USD Thousand)
• Table 25. Rest of MEA Needle Free Injection System Market, by Usability - Revenue and Forecast to 2028 (USD Thousand)
• Table 26. Rest of MEA Needle Free Injection System Market, by Site of Delivery- Revenue and Forecast to 2028 (USD Thousand)
• Table 27. Rest of MEA Needle Free Injection System Market, by Application - Revenue and Forecast to 2028 (USD Thousand)
• Table 28. Rest of MEA Needle Free Injection System Market, by End User - Revenue and Forecast to 2028 (USD Thousand)
• Table 29. Organic Developments Done by Companies
• Table 30. Inorganic Developments Done by Companies
• Table 31. Glossary of Terms

List Of Figures

• Figure 1. MEA Needle Free Injection Systems Market Segmentation
• Figure 2. MEA Needle Free Injection Systems Market, By Country
• Figure 3. MEA Needle Free Injection Systems Market Overview
• Figure 4. Fillable Needle-Free Injectors Segment Held Largest Share of Product Segment in MEA Needle Free Injection Systems Market
• Figure 5. Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period
• Figure 6. MEA: PEST Analysis
• Figure 7. MEA Needle Free Injection Systems Market Impact Analysis of Driver and Restraints
• Figure 8. MEA Needle Free Injection System Market - Revenue Forecast and Analysis - 2019-2028
• Figure 9. MEA Needle Free Injection Systems Market, by Product 2022 & 2028 (%)
• Figure 10. Fillable Needle Free Injectors: Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 11. Prefilled Needle Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 12. MEA Needle Free Injection Systems Market, by Technology 2022 & 2028 (%)
• Figure 13. Jet-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 14. Spring-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 15. Microarray Patch Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 16. Others - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 17. MEA Needle Free Injection Systems Market, by Type 2022 & 2028 (%)
• Figure 18. Liquid-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 19. Projectile-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 20. Powder-Based Needle-Free Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 21. MEA Needle Free Injection Systems Market, by Usability 2022 & 2028 (%)
• Figure 22. Disposable - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 23. Reusable - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 24. MEA Needle Free Injection Systems Market, by Site of Delivery 2022 & 2028 (%)
• Figure 25. Subcutaneous Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 26. Intramuscular Injector - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 27. Intradermal Injectors - Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 28. MEA Needle Free Injection Systems Market, by Application 2022 & 2028 (%)
• Figure 29. Vaccine Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 30. Insulin Delivery - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 31. Pain Management - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 32. Oncology - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 33. Dermatology - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 34. Others - Market Revenue and Forecasts to 2028 (US$ Thousand)
• Figure 35. MEA Needle Free Injection Systems Market, by End User 2022 & 2028 (%)
• Figure 36. Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 37. Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 38. Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 39. Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 40. Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)
• Figure 41. MEA: Needle Free Injection System Market, by Key Country - Revenue (2022) (USD Thousand)
• Figure 42. MEA: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
• Figure 43. Saudi Arabia: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
• Figure 44. South Africa: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
• Figure 45. UAE: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
• Figure 46. Rest of MEA: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
• Figure 47. Growth Strategies Done by the Companies in the Market (%)

The Middle East & Africa needle-free injection systems market is expected to grow from US$ 7.25 million in 2022 to US$ 17.89 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028.

Increasing Incidence of Communicable Diseases due to Needlestick Injuries Boost the Middle East & Africa Needle-Free Injection Systems Market

Needlestick injuries (NSIs) are one of the major concerns for most healthcare providers, and it is considered one of the most serious health and safety threats. The pooled prevalence of needlestick injuries among healthcare workers in 2020 was 32.4%. Further, according to the article published by the International Journal of Environment Research & Public Health 2022, the incidence of NSIs in Saudi Arabia is highest among physicians (36%), followed by nurses (34.8%), dentists (29.2%), and medical technologists (21.1%). Thus, above-mentioned factors are boosting the growth of the Middle East & Africa needle-free injection systems market .

Middle East & Africa Needle-Free Injection Systems market Overview

The Middle East & Africa needle-free injection system market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Saudi Arabia holds the largest share of the Middle East & Africa needle-free injection systems market owing to several factors such as increasing strategic initiatives by market players for launching their products in the region, rising incidence of chronic diseases, and growing healthcare infrastructure along with the increasing need for vaccines in the region.

Saudi Arabia is one of the fastest-growing regions in the Middle East & Africa, whose growth is driven by the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and autoimmune diseases. Rising awareness of health issues and growing adoption of needle-free injections for injectable drugs are the factors fueling the needle-free injection systems market growth. The burden of chronic diseases is significant in Saudi Arabia, which is expected to increase the demand for the Middle East & Africa needle-free injection systems market.

The World Health Organization has ranked Saudi Arabia as having the second-highest rate of diabetes in the Middle East and seventh-highest in the world. It is estimated that 7 million have diabetes and more than 3 million have pre-diabetes in Saudi Arabia. Over the last two decades, in Saudi, there has been a rise in the expenses of healthcare and treatment of diabetes by more than 500%. In diabetic patients, needle-free injectors can be used to inject insulin as a painless and easy-to-use treatment. Thus, the demand for needle-free injection systems is increasing, boosting the Middle East & Africa needle-free injection systems market growth.

Middle East & Africa Needle-Free Injection Systems Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Needle-Free Injection Systems Market Segmentation

The Middle East & Africa needle-free injection systems market is segmented on the basis of product, technology, type, durability, and country. Based on product, the Middle East & Africa needle-free injection systems market is bifurcated into fillable needle-free injectors and prefilled needle-free injectors. The fillable needle-free injectors segment held a larger share of the market in 2022.

Based on technology, the Middle East & Africa needle-free injection systems market is segmented into jet-based needle-free injectors, spring-based needle-free injectors, microarray patch injectors, and others. The jet-based needle-free injectors segment registered the largest share of the market in 2022.

Based on type, the Middle East & Africa needle-free injection systems market is segmented into liquid-based needle-free injectors, projectile-based needle-free injectors, and powder-based needle-free injectors. The liquid-based needle-free injectors segment registered the largest share of the market in 2022.

Based on durability, the Middle East & Africa needle-free injection systems market is bifurcated into disposable and reusable. The reusable segment held a larger share of the market in 2022.

Based on site of delivery, the Middle East & Africa needle-free injection systems market is segmented into subcutaneous injectors, intramuscular injectors, and intradermal injectors. The subcutaneous injectors segment held the largest share of the market in 2022.

Based on application, the Middle East & Africa needle-free injection systems market is segmented into vaccine delivery, insulin delivery, oncology, pain management, dermatology, and others. The vaccine delivery segment held the largest share of the market in 2022.

Based on end user, the Middle East & Africa needle-free injection systems market is segmented into hospitals, home care settings, research laboratories, pharmaceutical and biotechnology companies, and others. The hospitals segment held the largest share of the market in 2022.

Based on country, the Middle East & Africa needle-free injection systems market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the market in 2022.

Aijex Pharma International Inc., Crossject, Ferring B.V., and Zealand Pharma A/S are the leading companies operating in the needle-free injection systems market in the Middle East & Africa.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa needle-free injection systems market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa needle-free injection systems market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the needle-free injection systems market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

• 1.1 Study Scope
• 1.2 The Insight Partners Research Report Guidance
• 1.3 Market Segmentation
  • 1.3.1 MEA Needle Free Injection Systems Market - By Product
  • 1.3.2 MEA Needle Free Injection Systems Market - By Technology
  • 1.3.3 MEA Needle Free Injection Systems Market - By Type
  • 1.3.4 MEA Needle Free Injection Systems Market - By Usability
  • 1.3.5 MEA Needle Free Injection Systems Market - By Site of Delivery
  • 1.3.6 MEA Needle Free Injection Systems Market - By Application
  • 1.3.7 MEA Needle Free Injection Systems Market - By End User
  • 1.3.8 MEA Needle Free Injection Systems Market - By Country

2. MEA Needle Free Injection Systems Market- Key Takeaways

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. MEA Needle Free Injection Systems Market - Market Landscape

• 4.1 Overview
• 4.2 MEA PEST Analysis
• 4.3 Expert Opinion

5. MEA Needle Free Injection Systems Market - Key Market Dynamics

• 5.1 Market Drivers
  • 5.1.1 Increasing Incidence of Communicable Diseases Due to Needlestick Injuries
  • 5.1.2 Advantages of Using Self-injection Devices
• 5.2 Market Restraints
  • 5.2.1 Higher Development Costs of Needle Free Injectors Compared to Conventional Injection Systems
• 5.3 Market Opportunities
  • 5.3.1 Rising Demand for Vaccines and Biosimilars
• 5.4 Future Trends
  • 5.4.1 Surge in New Technologies for Needle Free Injection System
• 5.5 Impact Analysis

6. Needle Free Injection System Market - MEA Analysis

• 6.1 MEA Needle Free Injection System Marker Revenue Forecast and Analysis

7. MEA Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Product

• 7.1 Overview
• 7.2 MEA Needle Free Injection Systems Market, By Product 2022 & 2028 (%)
• 7.3 Fillable Needle Free Injectors
  • 7.3.1 Overview
  • 7.3.2 Fillable Needle Free Injectors: Revenue and Forecast to 2028 (US$ Thousand)
• 7.4 Prefilled Needle Free Injectors
  • 7.4.1 Overview
  • 7.4.2 Prefilled Needle Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

8. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Technology

• 8.1 Overview
• 8.2 MEA Needle Free Injection Systems Market, By Technology 2022 & 2028 (%)
• 8.3 Jet-Based Needle-Free Injectors
  • 8.3.1 Overview
  • 8.3.2 Jet-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.4 Spring-Based Needle-Free Injectors
  • 8.4.1 Overview
  • 8.4.2 Spring-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.5 Microarray Patch Injectors
  • 8.5.1 Overview
  • 8.5.2 Microarray Patch Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 8.6 Others
  • 8.6.1 Overview
  • 8.6.2 Others - Revenue and Forecast to 2028 (US$ Thousand)

9. Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Type

• 9.1 Overview
• 9.2 MEA Needle Free Injection Systems Market, By Type 2022 & 2028 (%)
• 9.3 Liquid-Based Needle-Free Injectors
  • 9.3.1 Overview
  • 9.3.2 Liquid-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 9.4 Projectile-Based Needle-Free Injectors
  • 9.4.1 Overview
  • 9.4.2 Projectile-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 9.5 Powder-Based Needle-Free Injectors
  • 9.5.1 Overview
  • 9.5.2 Powder-Based Needle-Free Injectors - Revenue and Forecast to 2028 (US$ Thousand)

10. MEA Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Usability

• 10.1 Overview
• 10.2 MEA Needle Free Injection Systems Market, By Usability 2022 & 2028 (%)
• 10.3 Disposable
  • 10.3.1 Overview
  • 10.3.2 Disposable - Revenue and Forecast to 2028 (US$ Thousand)
• 10.4 Reusable
  • 10.4.1 Overview
  • 10.4.2 Reusable - Revenue and Forecast to 2028 (US$ Thousand)

11. MEA Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Site of Delivery

• 11.1 Overview
• 11.2 MEA Needle Free Injection Systems Market, By Site of Delivery 2022 & 2028 (%)
• 11.3 Subcutaneous Injectors
  • 11.3.1 Overview
  • 11.3.2 Subcutaneous Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 11.4 Intramuscular Injectors
  • 11.4.1 Overview
  • 11.4.2 Intramuscular Injectors - Revenue and Forecast to 2028 (US$ Thousand)
• 11.5 Intradermal Injectors
  • 11.5.1 Overview
  • 11.5.2 Intradermal Injectors - Revenue and Forecast to 2028 (US$ Thousand)

12. MEA Needle Free Injection Systems Market Analysis and Forecasts To 2028 - By Application

• 12.1 Overview
• 12.2 MEA Needle Free Injection Systems Market, By Application 2022 & 2028 (%)
• 12.3 Vaccine Delivery
  • 12.3.1 Overview
  • 12.3.2 Vaccine Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.4 Insulin Delivery
  • 12.4.1 Overview
  • 12.4.2 Insulin Delivery - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.5 Pain Management
  • 12.5.1 Overview
  • 12.5.2 Pain Management - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.6 Oncology
  • 12.6.1 Overview
  • 12.6.2 Oncology - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.7 Dermatology
  • 12.7.1 Overview
  • 12.7.2 Dermatology - Market Revenue and Forecast to 2028 (US$ Thousand)
• 12.8 Others
  • 12.8.1 Overview
  • 12.8.2 Others - Market Revenue and Forecast to 2028 (US$ Thousand)

13. MEA Needle Free Injection Systems Market Analysis- By End User

• 13.1 Overview
• 13.2 MEA Needle Free Injection Systems Market, By End User 2022 & 2028 (%)
• 13.3 Pharmaceutical and Biotechnology Companies
  • 13.3.1 Overview
  • 13.3.2 Pharmaceutical and Biotechnology Companies - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.4 Hospitals
  • 13.4.1 Overview
  • 13.4.2 Hospitals - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.5 Research Laboratories
  • 13.5.1 Overview
  • 13.5.2 Research Laboratories - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.6 Home Care Settings
  • 13.6.1 Overview
  • 13.6.2 Home Care Settings - Market Revenue and Forecasts To 2028 (US$ Thousand)
• 13.7 Other End User
  • 13.7.1 Overview
  • 13.7.2 Other End User - Market Revenue and Forecasts To 2028 (US$ Thousand)

14. MEA Needle Free Injection Systems Market Revenue and Forecasts to 2028 - Country Analysis

• 14.1 Overview
  • 14.1.1 MEA: Needle Free Injection System Market, by Country, 2022 & 2028 (%)
    • 14.1.1.1 Saudi Arabia: Needle Free Injection System Market- Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.1.1 Saudi Arabia: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.1.2 Saudi Arabia: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousand)
      • 14.1.1.1.3 Saudi Arabia: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousand)
      • 14.1.1.1.4 Saudi Arabia: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousand)
      • 14.1.1.1.5 Saudi Arabia: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousand)
      • 14.1.1.1.6 Saudi Arabia: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousand)
      • 14.1.1.1.7 Saudi Arabia: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousand)
      • 14.1.1.1.8 Saudi Arabia: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousand)
    • 14.1.1.2 South Africa: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.2.1 South Africa: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.2.2 South Africa: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousand)
      • 14.1.1.2.3 South Africa: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousand)
      • 14.1.1.2.4 South Africa: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousand)
      • 14.1.1.2.5 South Africa: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousand)
      • 14.1.1.2.6 South Africa: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousand)
      • 14.1.1.2.7 South Africa: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousand)
      • 14.1.1.2.8 South Africa: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousand)
    • 14.1.1.3 UAE: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.3.1 UAE: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.3.2 UAE: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousand)
      • 14.1.1.3.3 UAE: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousand)
      • 14.1.1.3.4 UAE: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousand)
      • 14.1.1.3.5 UAE: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousand)
      • 14.1.1.3.6 UAE: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousand)
      • 14.1.1.3.7 UAE: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousand)
      • 14.1.1.3.8 UAE: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousand)
    • 14.1.1.4 Rest of MEA: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.4.1 Rest of MEA: Needle Free Injection System Market - Revenue and Forecast to 2028 (USD Thousand)
      • 14.1.1.4.2 Rest of MEA: Needle Free Injection System Market, by Product, 2019-2028 (USD Thousand)
      • 14.1.1.4.3 Rest of MEA: Needle Free Injection System Market, by Technology, 2019-2028 (USD Thousand)
      • 14.1.1.4.4 Rest of MEA: Needle Free Injection System Market, by Type, 2019-2028 (USD Thousand)
      • 14.1.1.4.5 Rest of MEA: Needle Free Injection System Market, by Usability, 2019-2028 (USD Thousand)
      • 14.1.1.4.6 Rest of MEA: Needle Free Injection System Market, by Site of Delivery, 2019-2028 (USD Thousand)
      • 14.1.1.4.7 Rest of MEA: Needle Free Injection System Market, by Application, 2019-2028 (USD Thousand)
      • 14.1.1.4.8 Rest of MEA: Needle Free Injection System Market, by End User, 2019-2028 (USD Thousand)

15. Needle-Free Injection System Market-Industry Landscape

• 15.1 Overview
• 15.2 Growth Strategies Done by the Companies in the Market (%)
• 15.3 Organic Developments
  • 15.3.1 Overview
• 15.4 Inorganic Developments
  • 15.4.1 Overview

16. Company Profiles

• 16.1 Crossject
  • 16.1.1 Key Facts
  • 16.1.2 Business Description
  • 16.1.3 Products and Services
  • 16.1.4 Financial Overview
  • 16.1.5 SWOT Analysis
  • 16.1.6 Key Developments
• 16.2 Zealand Pharma A/S
  • 16.2.1 Key Facts
  • 16.2.2 Business Description
  • 16.2.3 Products and Services
  • 16.2.4 Financial Overview
  • 16.2.5 SWOT Analysis
  • 16.2.6 Key Developments
• 16.3 Medical International Technologies (MIT Canada) Inc.
  • 16.3.1 Key Facts
  • 16.3.2 Business Description
  • 16.3.3 Products and Services
  • 16.3.4 Financial Overview
  • 16.3.5 SWOT Analysis
  • 16.3.6 Key Developments
• 16.4 NuGen Medical Devices
  • 16.4.1 Key Facts
  • 16.4.2 Business Description
  • 16.4.3 Products and Services
  • 16.4.4 Financial Overview
  • 16.4.5 SWOT Analysis
  • 16.4.6 Key Developments
• 16.5 Ferring B.V.
  • 16.5.1 Key Facts
  • 16.5.2 Business Description
  • 16.5.3 Products and Services
  • 16.5.4 Financial Overview
  • 16.5.5 SWOT Analysis
  • 16.5.6 Key Developments

17. Appendix

• 17.1 About The Insight Partners
• 17.2 Glossary of Terms